S. P. Yazdankhah and D. A. Caugant, Neisseria meningitides: an overview of the carriage state, J MedMicrobiol, vol.53, pp.821-853, 2004.

M. K. Taha, A. E. Deghmane, A. Antignac, M. L. Zarantonelli, and M. Laribe, The duality of virulence and transmissibility in Neisseria meningitidis, Trends Microbiol, vol.10, issue.8, pp.376-82, 2002.

I. Parent-du-châtelet, P. Barboza, and M. K. Taha, W135 invasive meningococcal infections imported from Sub-Saharan Africa to France, Euro Surveill, vol.17, issue.21, p.20181, 2012.

, Public health management of sporadic cases of invasive meningococcal disease and their contacts, 2010.

L. E. Cuevas, P. Kazembe, G. K. Mughogho, G. S. Tillotson, and C. A. Hart, Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampicin, J Infect Dis, vol.1995171, issue.3, pp.728-759

A. B. Kaiser, C. H. Hennekens, M. S. Saslaw, P. S. Hayes, and J. V. Bennett, Seroepidemiology and chemoprophylaxis disease due to sulfonamide-resistant Neisseria meningitidis in a civillian population, J Infect Dis, vol.130, issue.3, pp.217-241, 1974.

W. Deal and E. Sanders, Efficacy of rifampicin in treatment of meningococcal carriers, N Engl J Med, vol.281, issue.12, pp.641-646, 1969.

I. S. Blakebrough and H. M. Gilles, The effect of rifampicin on meningococcal carriage in family contacts in northern Nigeria, J Infect, vol.2, issue.2, pp.137-180, 1980.

R. B. Guttler, G. W. Counts, C. K. Avent, and H. N. Beaty, Effect of rifampin and minocycline on meningococcal carrier rates, J Infect Dis, vol.124, issue.2, pp.199-205, 1971.

A. Skoczynska, C. Ruckly, H. E. Taha, and M. K. , Molecular characterization of resistance to rifampicin in clinical isolates of Neisseria meningitidis, Clin Microbiol Infect, vol.15, pp.1178-81, 2009.

I. Pasteur, J. M. Alonso, M. K. Taha, A. E. Deghmane, C. Ruckly et al., Rapport annuel du CNR des Méningocoques : synthèse de, 2006.

, on the prevention of invasive meningococcal disease, Direction Générale de la Santé. Instruction n° DGS/RI1/2011/33 du 27 janvier 2011 relative à la prophylaxie des infections invasives à méningocoque, 2011.

P. Yagupsky, S. Ashkenazi, and C. Block, Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxis, Lancet, vol.341, issue.8853, pp.1152-1155, 1993.

E. R. Cooper, R. Ellison, G. Smith, M. Blaser, L. Reller et al., Rifampicin-resistant meningococcal dosease in patient given prophylactic rifampicin, J Pediatr, vol.108, issue.1, pp.93-96, 1986.

R. Cooke, T. Riordan, D. Jones, and M. Painter, Secondary cases of meningococcal infection among close family and household contacts in England and Wales, BM J, vol.298, issue.6673, pp.555-58, 1989.

A. E. Deghmane, I. Parent-du-chatelet, and M. Szatanik, Emergence of new virulent Neisseria meningitidis serogroup C sequence type 11 isolates in France, J Infect Dis, vol.202, pp.247-50, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-02085474

, Avis relatif à la vaccination méningococcique conjugué de sérogroupe C. [Opinion on the meningococcal conjugate vaccine for serogroup C

. Haut-conseil-de-santé-publique, , 2009.

. Haut-conseil-de-la-santé-publique, Avis relatif à l'antibiothérapie des sujets contacts lors de situations impliquant plusieurs cas d'infection invasive à méningocoque dans une même communauté. [Opinion on the antibiotic therapy for contacts in situations involving several cases of invasive meningococcal disease in a community

. Haut-conseil-de-santé-publique, , 2012.

, on the prevention of invasive meningococcal disease, Direction Générale de la Santé. Instruction n° DGS/RI1/2011/33 du 27 janvier 2011 relative à la 20. prophylaxie des infections invasives à méningocoque, 2011.